Abstract
MicroRNAs (miRNAs) are small non-coding RNAs exhibiting critical functions as post-transcriptional regulators. Due to the importance and extensive influence of miRNAs on genes, dysregulation of miRNAs has been associated with various types of cancer, with more prominent being colorectal carcinoma (CRC). Increasing evidence suggests that miRNAs mediate the initiation and development of CRC and also act as potential biomarkers for both diagnosis and prognosis. In this review, we summarize the recent advancement of miRNA research in CRC, in particular, the miRNAs which interact with critical pathways such as p53, NF-kappa B, beta-catenin pathways and also play a significant role in the regulation of EMT and maintenance of cancer stem cell.
Keywords: miRNA, colorectal carcinoma, carcinogenesis, metastasis, small non-coding RNAs, post-transcriptional regulators, biomarkers, p53, NF-kappa B, cancer stem cell
Current Pharmaceutical Design
Title:Roles of miRNA in the Initiation and Development of Colorectal Carcinoma
Volume: 19 Issue: 7
Author(s): Yiming Ma, Weiwei Li and Hongying Wang
Affiliation:
Keywords: miRNA, colorectal carcinoma, carcinogenesis, metastasis, small non-coding RNAs, post-transcriptional regulators, biomarkers, p53, NF-kappa B, cancer stem cell
Abstract: MicroRNAs (miRNAs) are small non-coding RNAs exhibiting critical functions as post-transcriptional regulators. Due to the importance and extensive influence of miRNAs on genes, dysregulation of miRNAs has been associated with various types of cancer, with more prominent being colorectal carcinoma (CRC). Increasing evidence suggests that miRNAs mediate the initiation and development of CRC and also act as potential biomarkers for both diagnosis and prognosis. In this review, we summarize the recent advancement of miRNA research in CRC, in particular, the miRNAs which interact with critical pathways such as p53, NF-kappa B, beta-catenin pathways and also play a significant role in the regulation of EMT and maintenance of cancer stem cell.
Export Options
About this article
Cite this article as:
Ma Yiming, Li Weiwei and Wang Hongying, Roles of miRNA in the Initiation and Development of Colorectal Carcinoma, Current Pharmaceutical Design 2013; 19 (7) . https://dx.doi.org/10.2174/138161213804805784
DOI https://dx.doi.org/10.2174/138161213804805784 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Beyond Thymidylate Synthase and Dihydrofolate Reductase: Impact of Non-coding microRNAs in Anticancer Chemoresistance
Current Enzyme Inhibition Malignant Pleural Mesothelioma in 2011. Is there a Gold Standard Therapy?
Current Respiratory Medicine Reviews AMPK as a New Attractive Therapeutic Target for Disease Prevention: The Role of Dietary Compounds AMPK and Disease Prevention
Current Drug Targets Aberrant Regulation of Translation Initiation in Tumorigenesis
Current Molecular Medicine New Direct and Frontal Tissue Acquisition Tools for Gene Expression Analysis in Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Positron Emitting Tracers in Pre-Clinical Drug Development
Current Radiopharmaceuticals Vitiligo in Children: A Birds Eye View
Current Pediatric Reviews Anti-Galectin Compounds as Potential Anti-Cancer Drugs
Current Medicinal Chemistry HSP60 as a Drug Target
Current Pharmaceutical Design Molecular Markers of Glioblastoma and the Potential for Integration with Imaging: the Future for Assigning Prognosis and Best Treatment Strategy
Current Molecular Imaging (Discontinued) Targeting Calcium Channels to Block Tumor Vascularization
Recent Patents on Anti-Cancer Drug Discovery Linkage of Stress with Neuromuscular Disorders
CNS & Neurological Disorders - Drug Targets The Potential of T Cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Designing Novel Immunotherapy for Bladder Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Advances in Nanocarriers for Anticancer Drugs Delivery
Current Medicinal Chemistry Development of Amino Acid-Based Radiopharmaceuticals for Tumor Imaging
Mini-Reviews in Medicinal Chemistry LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers
Current Cancer Drug Targets Molecular Targeted Therapy in Melanoma: A Way to Reverse Resistance to Conventional Drugs
Current Drug Delivery Synthesis of New Curcumin-like Pentadienones by O- and C-glycosylation
Current Organic Chemistry An Overview on Fibroblast Growth Factors: Structural, Functional and Therapeutic Implications
Current Proteomics microRNA, Cancer and Cancer Chemoprevention
Current Molecular Pharmacology